Stock Markets Analysis & Opinion

All eight indexes on our world watch list have posted gains for 2017 through December 11. The top performer thus far is Hong Kong's Hang Seng with a gain of 31.66%, followed by India's BSE SENSEX at...

Long Splunk (NASDAQ:SPLK) Long Supervalu (NYSE:SVU) Short Anadarko Petroleum (NYSE:APC) Original Post

Trump Rally Stalling Before Tax Cut And Budget VotesI will update around 6:55 a.m.Pre-Open AnalysisThe Emini has had a weak 3-day rally after two big bear days on the daily chart. The bulls want a...

The four blockchain payments stocks on our list leverage blockchain technology for the payment processing industrySmallCapPower | December 11, 2017: According to Don Tapscott, the author of Blockchain...

Picking up a position in a healthcare stock ahead of a major catalyst can be a risky strategy but is also one that serves up the potential for a high degree of reward on the position in question.In...

Listen to the Podcast Audio: Click Here Mike Gleason: It is my privilege now to welcome in Michael Pento, President and founder of Pento Portfolio Strategies and author of the book, The Coming Bond...

Valuation Back To Prior PeakOpinionAll of the indexes closed higher Friday with positive internals on the NYSE and NASDAQ as volumes declined from the prior session. Some new closing highs were...

DAX trying to breakout this trading range Original post

Prima BioMed has changed its name to Immutep Ltd ADR (NASDAQ:IMMP) following shareholder approval in November. It reported an encouraging 33% preliminary response rate from the first two cohorts of...

I often look at sector composition trends for the S&P 500, and one of the areas that is really standing out for me is the Information Technology sector (GICS classification). There's a lot of...

The S&P 500 was able to squeak out a gain last week, finishing up 0.35% with the Dow closing up 0.40% but we saw a decline in small caps as the Russell 2000 closed lower by 1.05% and international...

Gilead Sciences Inc. (NASDAQ:GILD) announced long-term follow-up data from a phase II study, evaluating its chimeric antigen receptor T-cell (CAR-T) therapy, Yescarta (axicabtagene ciloleucel), for...

Strong H118 results and positive order book development cause us to raise estimates, especially for the current year with better dividend prospects also. UK economic uncertainty will provide...

SUPERVALU INC. (NYSE:SVU) recently concluded the acquisition of Associated Grocers, for approximately $193 million. This Florida-based company is likely to be a profitable inclusion to...